The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Janssen Sciences Ireland UC .

Filed returns
28
match these filters
Matching filed returns per period 0 1 2 3 5 May–Aug 2018: 1 filed returns Sep–Dec 2018: 1 filed returns Jan–Apr 2019: 1 filed returns May–Aug 2019: 1 filed returns Jan–Apr 2020: 3 filed returns May–Aug 2020: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 2 filed returns Sep–Dec 2021: 2 filed returns Jan–Apr 2022: 1 filed returns Sep–Dec 2022: 1 filed returns Jan–Apr 2023: 4 filed returns Sep–Dec 2023: 1 filed returns Sep–Dec 2024: 2 filed returns Jan–Apr 2025: 2 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 2 filed returns May–Aug 2026: 1 filed returns 2019 2020 2021 2022 2023 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Janssen Sciences Ireland UC Health Engagement with the Departments of Health and Enterprise regarding the national life science strategy (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2026 Janssen Sciences Ireland UC Health Meeting with Department of Health (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2026 Janssen Sciences Ireland UC Economic Development and Industry Engagements with Irish policymakers on national life sciences policy (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2025 Janssen Sciences Ireland UC Health Engagement with the Department of Health on the Life Sciences Strategy (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2025 Janssen Sciences Ireland UC Economic Development and Industry Introductions to new Ministers outlining industry priorities (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2025 Janssen Sciences Ireland UC Economic Development and Industry Interaction with Secretary General of the Department of Health (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2024 Janssen Sciences Ireland UC Health Engagement with Oireachtas members re new development funding for medicines due for reimbursement in 2025. (Matters involving public funds) 3 On lobbying.ie
Sep–Dec 2024 Janssen Sciences Ireland UC Health Communication with Robert Watt re reimbursement process reform (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 Janssen Sciences Ireland UC Budgetary matters Engagement with Government Ministers about Budget 2024 (Matters involving public funds) 9 On lobbying.ie
Jan–Apr 2023 Janssen Sciences Ireland UC Health Discussion at Health Summit on proposed reforms to medicines reimbursement (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2023 Janssen Sciences Ireland UC Health Sharing information on life sciences sector in Ireland & on EU pharmaceutical package (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 Janssen Sciences Ireland UC Health Discussion at IPHA Conference on Proposed Reforms to Medicines Reimbursement (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2023 Janssen Sciences Ireland UC Health Sharing Invite to discussion series on 'Ireland & the European Health Union Series: What will it mean for rare disease'' (Public policy or programme) 15 On lobbying.ie
Sep–Dec 2022 Janssen Sciences Ireland UC Health Sharing Invite to discussion series on 'Ireland & the European Health Union Series: Opportunities to Improve Irish Healthcare' (Public policy or programme) 23 On lobbying.ie
Jan–Apr 2022 Janssen Sciences Ireland UC Health Invite to webinar series on the 'Future of Value Based Healthcare in Ireland', RCSI Dublin (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2021 Janssen Sciences Ireland UC Health Sharing information of patient research on clinical depression (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2021 Janssen Sciences Ireland UC Health Sharing information on European Beating Cancer Plan and impact on Ireland (Public policy or programme) 10 On lobbying.ie
May–Aug 2021 Janssen Sciences Ireland UC Health Sharing copy of a new report on Cell and Gene therapies (Public policy or programme) 8 On lobbying.ie
May–Aug 2021 Janssen Sciences Ireland UC Health Invitation to Discuss Patient Research on Mental Illness (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2021 Janssen Sciences Ireland UC Health Sharing progress and information on Janssen COVID19 Vaccine clinical development, supply updates and public communication (Public policy or programme) 11 On lobbying.ie
May–Aug 2020 Janssen Sciences Ireland UC Health Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Health Sharing update on the timeline for the development of JnJ vaccine for COVID-19 and about some of JnJ’s local efforts to assist the health service during pandemic (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Economic Development and Industry Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Health Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) 9 On lobbying.ie
May–Aug 2019 Janssen Sciences Ireland UC Health Invite to visit Janssen garden ‘Grounded’ at Bloom in the Park festival (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2019 Janssen Sciences Ireland UC Health Outcomes based contracting for medicines (Public policy or programme) 5 On lobbying.ie
Sep–Dec 2018 Janssen Sciences Ireland UC Health Outcomes based contracting for medicines (Public policy or programme) 6 On lobbying.ie
May–Aug 2018 Janssen Sciences Ireland UC Health Neuroscience Disease Areas (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 23 82.1%
Economic Development and Industry 4 14.3%
Budgetary matters 1 3.6%